Loading chat...

AZ SB1453

Bill

Status

Introduced

2/1/2023

Primary Sponsor

Thomas Shope

Click for details

Origin

Senate

Fifty-sixth Legislature - First Regular Session (2023)

AI Summary

  • Prohibits processing, manufacturing, distributing, or selling hemp-derived manufactured impairing cannabinoids in Arizona except through licensed nonprofit medical marijuana dispensaries or marijuana establishments with Department of Health Services approval.

  • Defines "hemp-derived manufactured impairing cannabinoids" to include delta-8 THC, delta-9 THC over 0.3%, delta-10 THC, hexahydrocannabinol, tetrahydrocannabiphorol, and related synthetic cannabinoids derived from chemically converting naturally occurring hemp cannabinoids.

  • Requires Department of Health Services to adopt regulations governing processing, manufacturing, and sale of these products, including labeling that states "this product is not marijuana" and warning requirements about health risks.

  • Establishes that violations are class 2 misdemeanors and allows private civil causes of action for damages, with funds from medical marijuana and Smart and Safe Arizona funds allocated to implementation and poison control center education.

  • Exempts the Department of Health Services from standard rulemaking procedures for 36 months and makes the chapter effective only upon affirmative vote of at least three-fourths of both legislative houses.

Legislative Description

Hemp-derived impairing cannabinoids; regulation

Prohibition

Last Action

Senate HHS Committee action: Failed To Pass, voting: (3-4-0-0)

2/14/2023

Committee Referrals

Rules2/1/2023
Health and Human Services2/1/2023

Full Bill Text

No bill text available